Large gap with delayed quotes
Analysis date: 24.07.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 02.01.2026.
Interest
Very weak
Very weak
One star since 07.07.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 10.07.2026 at a price of 78.11.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 30.06.2026.
4wk Rel Perf
-5.07%
-5.07%
The four-week dividend-adjusted underperformance versus SP500 is 5.07%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 02.01.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.06%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.13%.
Mkt Cap in $bn
10.38
10.38
With a market capitalization >$8bn, GLOBUS MEDICAL INCO. is considered a large-cap stock.
G/PE Ratio
0.96
0.96
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
13.23
13.23
The estimated PE is for the year 2028.
LT Growth
12.74%
12.74%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
46
46
For 1% of index variation, the stock varies on average by 0.46%.
Correlation
0.11
0.11
Stock movements are totally independent of index variations.
Value at Risk
18.36
18.36
The value at risk is estimated at USD 18.36. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2018
27.07.2018